Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial

MLA

Camenzind, E., et al. “Stent Thrombosis and Major Clinical Events at 3 Years after Zotarolimus-Eluting or Sirolimus-Eluting Coronary Stent Implantation: A Randomised, Multicentre, Open-Label, Controlled Trial.” The Lancet (London), 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1366699584&authtype=sso&custid=ns315887.

APA

Camenzind, E., Wijns, W., Mauri, L., Kurowski, V., Parikh, K., Gao, R., Bode, C., Greenwood, J. P., Boersma, E., Vranckx, P., McFadden, E., Serruys, P. W., O’Neil, W. W., Jorissen, B., Leeuwen, F. van, Steg, P. G., Verheugt, F. W., & et al. (2012). Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial. The Lancet (London).

Chicago

Camenzind, E., W. Wijns, L. Mauri, V. Kurowski, K. Parikh, R. Gao, C. Bode, et al. 2012. “Stent Thrombosis and Major Clinical Events at 3 Years after Zotarolimus-Eluting or Sirolimus-Eluting Coronary Stent Implantation: A Randomised, Multicentre, Open-Label, Controlled Trial.” The Lancet (London). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1366699584&authtype=sso&custid=ns315887.